Evidence map›Paper›PMID 37671359›Full record

ArticlePeerJ2023

PM

Yuecheng Jiang, Yanzhe Peng, Xia Yang, Jiali Yu, Fuxun Yu, Jing Yuan, Yan Zha

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Long-term impact of PMClinical kidney journal · 2025
    Article
  5. Article
  6. PMToxics · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yuecheng Jiang *Zunyi Medical University, Guiyang, China.
Yanzhe Peng *Department of Nephrology, Guizhou Provincial People's Hospital, Guiyang, China.
Xia YangNHC Key Laboratory of Pulmonary Immunological Disease, Guizhou Provincial People's Hospital, Guiyang, China.
Jiali YuNHC Key Laboratory of Pulmonary Immunological Disease, Guizhou Provincial People's Hospital, Guiyang, China.
Fuxun YuNHC Key Laboratory of Pulmonary Immunological Disease, Guizhou Provincial People's Hospital, Guiyang, China.
Jing YuanDepartment of Nephrology, Guizhou Provincial People's Hospital, Guiyang, China.
Yan ZhaZunyi Medical University, Guiyang, China.
Guizhou Provincial People's Hospital · CNGuizhou University · CNZunyi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ambient fine particulate matter ≤ 2.5 µm (PM Methods: In this study, db/db mice were exposed to different dosage PM Results: The increasing of Oil Red staining area and adipose differentiation related protein (ADRP) expression detected by IHC staining indicated more ectopic lipid accumulation in kidney after PM

Indexed as

Diabetes Mellitus, ExperimentalHMGN1 ProteinLipid Metabolism DisordersAnimalsChromatography, LiquidKidneyLipid MetabolismLipidsMiceTandem Mass SpectrometryHMGN1 ProteinLipidsATGLDiabetes mellitusDiabetic kidney diseaseEctopic lipid accumulationHMGN1KIM-1PM2.5SREBP-1

Identifiers

PMID37671359
PMCPMC10476618
OpenAlexW4386349281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.